COVID-19 vaccines and thrombosis with thrombocytopenia syndrome
Journal
Expert review of vaccines
Date Issued
2021-07-08
Author(s)
Abstract
To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination.
Subjects
COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia
SDGs
Other Subjects
administration and dosage; adverse event; human; prevention and control; thrombocytopenia; thrombosis; COVID-19; COVID-19 Vaccines; Humans; Thrombocytopenia; Thrombosis
Type
review